Trial intelligence / Profile preview

Adjuvant PFL Chemotherapy After Radiotherapy in Advanced Nasopharyngeal Carcinoma

NCT00201344Phase 3Terminated

Sponsor
National Health Research Institutes
Start
Nov 1994
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of cisplatin, fluorouracil, folinic acid in nasopharyngeal carcinoma (NPC), sponsored by National Health Research Institutes. Started Nov 1994; status: terminated.

02

Drugs

cisplatinfluorouracilfolinic acid
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT00201344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00201344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call